Navigating the AI Ecosystem - AI's Evolving Role in Health Care
Participants can expect to learn about the origin and contributing factors in the rise of AI, especially with a focus in healthcare. The diversity of AI applications will be covered to include clinical and non clinical opportunities, sharing case use examples where AI is already in the research/piloting phases. The various phases of AI will be described with a focus on Generative AI and the foundation model. Participants will learn about the top priorities of health system AI in the near future and how to strategically think about considerations in building an AI program for their organization. They will also learn about AI adoption barriers, patient concerns and future clinician roles as we move into AI in healthcare.
Target Audience
Physicians
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Provide a landscape overview of AI and the market forces contributing to the resurgence of AI hype.
- Highlight AI applications and use cases from field happening today and in the near future.
- Outline a strategic roadmap for health care providers as they build a viable AI program.
Additional Information
Faculty
Andrew Rebhan
Consulting Director
Sg2
Planning committee
Sharon Ellis, MEd, BSN, RN
AVP Performance Improvement
Vizient Southern States
Amanda Logue, MD
Chief Medical Officer OLG / Regional Medical Director
Ochsner Health
Suresh Lakhanpal, MD
CEO, Phoebe Physicians
SVP Physician Services
Phoebe Putney Health System
Danny Branstetter, MD
Interim Chief Medical Officer, Kennestone Hospital
Wellstar Health System
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s):
PHYSICIAN
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re- certification. It is the responsibility
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General CE - Attendance